Ketamine clinics show promise for treatment-resistant depression

From cat tranquilizer to party drug to novel antidepressant, ketamine has come a long way in the past 55 years. Originally developed as an affordable and effective anesthetic, it has recently become the latest line of defense for treatment-resistant depression, anxiety, PTSD, OCD and even nerve-related pain disorders like fibromyalgia or neuropathy. In most cases, the treatment is offered in the form of infusion supervised by clinical coordinators and/or medical doctors. Currently, the treatment is considered an off-label use, meaning that it hasn’t been specifically approved by the FDA for these conditions but due to overall safety and effectiveness after multiple research studies and anecdotal evidence from ketamine clinic patients, the practice is slowly becoming more mainstream.

Read more at the Inquisitr.